drugset / Trial / NCT00002528

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer

NCT00002528

Phase 3 Completed 473 enrolled ETOP IBCSG Partners Foundation
RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Removing axillary lymph nodes may be effective in stopping the spread of breast cancer cells. It is not yet known if surgery to remove breast cancer is more effective with or without lymph node removal. PURPOSE: Randomized phase III trial to compare the effectiveness of breast surgery with or without removal of axillary lymph nodes in treating women who have stage I or stage IIA breast cancer.

Timeline

Start
1993-05
Primary completion
2002-12
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Background Tamoxifen Small molecule 20 mg Oral

Indications